vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Lovesac Co (LOVE). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $150.2M, roughly 1.9× Lovesac Co). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs -7.0%, a 103.4% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs 0.2%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs -22.6%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
The Lovesac Company is an American furniture retailer, specializing in a patented modular furniture system called Sactionals. Sactionals consist of two combinable pieces, “Seats” and “Sides,” as well as custom-fit covers and associated accessories. Lovesac also sells Sacs, a bag seat filled with a proprietary foam mixture.
ACAD vs LOVE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $150.2M |
| Net Profit | $273.6M | $-10.6M |
| Gross Margin | 90.8% | 56.1% |
| Operating Margin | 6.1% | -10.5% |
| Net Margin | 96.3% | -7.0% |
| Revenue YoY | 9.4% | 0.2% |
| Net Profit YoY | 90.3% | -114.0% |
| EPS (diluted) | $1.61 | $-0.72 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $150.2M | ||
| Q3 25 | $278.6M | $160.5M | ||
| Q2 25 | $264.6M | $138.4M | ||
| Q1 25 | $244.3M | $241.5M | ||
| Q4 24 | $259.6M | $149.9M | ||
| Q3 24 | $250.4M | $156.6M | ||
| Q2 24 | $242.0M | $132.6M | ||
| Q1 24 | $205.8M | $250.5M |
| Q4 25 | $273.6M | $-10.6M | ||
| Q3 25 | $71.8M | $-6.7M | ||
| Q2 25 | $26.7M | $-10.8M | ||
| Q1 25 | $19.0M | $35.3M | ||
| Q4 24 | $143.7M | $-4.9M | ||
| Q3 24 | $32.8M | $-5.9M | ||
| Q2 24 | $33.4M | $-13.0M | ||
| Q1 24 | $16.6M | $31.0M |
| Q4 25 | 90.8% | 56.1% | ||
| Q3 25 | 92.2% | 56.4% | ||
| Q2 25 | 92.2% | 53.7% | ||
| Q1 25 | 91.7% | 60.4% | ||
| Q4 24 | 91.6% | 58.5% | ||
| Q3 24 | 92.5% | 59.0% | ||
| Q2 24 | 92.5% | 54.3% | ||
| Q1 24 | 88.8% | 59.7% |
| Q4 25 | 6.1% | -10.5% | ||
| Q3 25 | 12.8% | -5.5% | ||
| Q2 25 | 12.2% | -10.8% | ||
| Q1 25 | 7.9% | 19.7% | ||
| Q4 24 | 59.1% | -5.2% | ||
| Q3 24 | 12.6% | -5.3% | ||
| Q2 24 | 12.6% | -13.5% | ||
| Q1 24 | 7.4% | 16.1% |
| Q4 25 | 96.3% | -7.0% | ||
| Q3 25 | 25.8% | -4.1% | ||
| Q2 25 | 10.1% | -7.8% | ||
| Q1 25 | 7.8% | 14.6% | ||
| Q4 24 | 55.4% | -3.3% | ||
| Q3 24 | 13.1% | -3.7% | ||
| Q2 24 | 13.8% | -9.8% | ||
| Q1 24 | 8.0% | 12.4% |
| Q4 25 | $1.61 | $-0.72 | ||
| Q3 25 | $0.42 | $-0.45 | ||
| Q2 25 | $0.16 | $-0.73 | ||
| Q1 25 | $0.11 | $2.22 | ||
| Q4 24 | $0.86 | $-0.32 | ||
| Q3 24 | $0.20 | $-0.38 | ||
| Q2 24 | $0.20 | $-0.83 | ||
| Q1 24 | $0.10 | $1.91 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $23.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $189.3M |
| Total Assets | $1.6B | $495.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $23.7M | ||
| Q3 25 | $258.0M | $34.2M | ||
| Q2 25 | $253.6M | $26.9M | ||
| Q1 25 | $217.7M | $83.7M | ||
| Q4 24 | $319.6M | $61.7M | ||
| Q3 24 | $155.1M | $72.1M | ||
| Q2 24 | $177.1M | $72.4M | ||
| Q1 24 | $204.7M | $87.0M |
| Q4 25 | $1.2B | $189.3M | ||
| Q3 25 | $917.3M | $197.5M | ||
| Q2 25 | $822.4M | $201.2M | ||
| Q1 25 | $765.2M | $216.4M | ||
| Q4 24 | $732.8M | $196.5M | ||
| Q3 24 | $577.2M | $202.1M | ||
| Q2 24 | $516.7M | $205.3M | ||
| Q1 24 | $464.0M | $217.5M |
| Q4 25 | $1.6B | $495.5M | ||
| Q3 25 | $1.3B | $493.7M | ||
| Q2 25 | $1.2B | $483.7M | ||
| Q1 25 | $1.1B | $532.3M | ||
| Q4 24 | $1.2B | $499.7M | ||
| Q3 24 | $976.9M | $481.1M | ||
| Q2 24 | $914.1M | $477.2M | ||
| Q1 24 | $855.1M | $482.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $-4.9M |
| Free Cash FlowOCF − Capex | — | $-10.2M |
| FCF MarginFCF / Revenue | — | -6.8% |
| Capex IntensityCapex / Revenue | — | 3.5% |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-13.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $-4.9M | ||
| Q3 25 | $74.3M | $12.2M | ||
| Q2 25 | $64.0M | $-41.4M | ||
| Q1 25 | $20.3M | $44.0M | ||
| Q4 24 | $40.4M | $-4.2M | ||
| Q3 24 | $63.2M | $6.2M | ||
| Q2 24 | $25.0M | $-7.0M | ||
| Q1 24 | $29.1M | $56.3M |
| Q4 25 | — | $-10.2M | ||
| Q3 25 | $73.9M | $7.8M | ||
| Q2 25 | — | $-50.0M | ||
| Q1 25 | — | $38.7M | ||
| Q4 24 | — | $-6.6M | ||
| Q3 24 | $63.2M | $119.0K | ||
| Q2 24 | — | $-14.3M | ||
| Q1 24 | — | $49.5M |
| Q4 25 | — | -6.8% | ||
| Q3 25 | 26.5% | 4.9% | ||
| Q2 25 | — | -36.1% | ||
| Q1 25 | — | 16.0% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | 25.2% | 0.1% | ||
| Q2 24 | — | -10.8% | ||
| Q1 24 | — | 19.8% |
| Q4 25 | — | 3.5% | ||
| Q3 25 | 0.1% | 2.7% | ||
| Q2 25 | — | 6.2% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | 0.0% | 3.9% | ||
| Q2 24 | — | 5.5% | ||
| Q1 24 | — | 2.7% |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 1.07× | 1.25× | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | — | ||
| Q2 24 | 0.75× | — | ||
| Q1 24 | 1.76× | 1.82× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
LOVE
| Showrooms | $102.7M | 68% |
| Internet | $37.3M | 25% |
| Other | $10.2M | 7% |
